Financial Architects (New Jersey)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,455
| Closed | -$228K | – | 316 |
|
|
2022
Q4 | $228K | Buy |
+1,455
| New | +$209K | 0.04% | 302 |
|
|
2022
Q1 | – | Sell |
-1,547
| Closed | -$268K | – | 339 |
|
|
2021
Q4 | $268K | Sell |
1,547
-680
| -31% | -$103K | 0.04% | 285 |
|
|
2021
Q3 | $324K | Buy |
+2,227
| New | +$326K | 0.05% | 252 |
|
|
2020
Q3 | – | Sell |
-1,387
| Closed | -$158K | – | 387 |
|
|
2020
Q2 | $158K | Hold |
1,387
| – | – | 0.04% | 273 |
|
|
2020
Q1 | $111K | Hold |
1,387
| – | – | 0.03% | 294 |
|
|
2019
Q4 | $148K | Hold |
1,387
| – | – | 0.03% | 277 |
|
|
2019
Q3 | $148K | Hold |
1,387
| – | – | 0.03% | 274 |
|
|
2019
Q2 | $141K | Sell |
1,387
-70
| -5% | -$6.73K | 0.03% | 313 |
|
|
2019
Q1 | $131K | Buy |
1,457
+11
| +0.8% | +$953 | 0.02% | 399 |
|
|
2018
Q4 | $120K | Sell |
1,446
-12
| -0.8% | -$1.13K | 0.02% | 363 |
|
|
2018
Q3 | $157K | Hold |
1,458
| – | – | 0.03% | 355 |
|
|
2018
Q2 | $160K | Buy |
1,458
+12
| +0.8% | +$1.25K | 0.03% | 308 |
|
|
2018
Q1 | $145K | Hold |
1,446
| – | – | 0.03% | 366 |
|
|
2017
Q4 | $143K | Sell |
1,446
-320
| -18% | -$30.3K | 0.02% | 408 |
|
|
2017
Q3 | $165K | Buy |
1,766
+100
| +6% | +$10.6K | 0.03% | 374 |
|
|
2017
Q2 | $185K | Buy |
1,666
+88
| +6% | +$9.3K | 0.03% | 331 |
|
|
2017
Q1 | $155K | Sell |
1,578
-4
| -0.3% | -$381 | 0.03% | 348 |
|
|
2016
Q4 | $145K | Buy |
1,582
+106
| +7% | +$9.14K | 0.03% | 310 |
|
|
2016
Q3 | $125K | Hold |
1,476
| – | – | 0.03% | 339 |
|
|
2016
Q2 | $120K | Buy |
1,476
+89
| +6% | +$6.78K | 0.03% | 331 |
|
|
2016
Q1 | $99K | Buy |
+1,387
| New | +$93K | 0.04% | 277 |
|
|
2015
Q3 | – | Sell |
-1,456
| Closed | -$106K | – | 380 |
|
|
2015
Q2 | $106K | Buy |
1,456
+111
| +8% | +$8.2K | 0.04% | 294 |
|
|
2015
Q1 | $103K | Sell |
1,345
-142
| -10% | -$10.2K | 0.04% | 278 |
|
|
2014
Q4 | $100K | Buy |
1,487
+11
| +0.7% | +$694 | 0.04% | 248 |
|
|
2014
Q3 | $90K | Buy |
1,476
+200
| +16% | +$12.3K | 0.04% | 239 |
|
|
2014
Q2 | $75K | Buy |
+1,276
| New | +$74.7K | 0.04% | 270 |
|
|
2013
Q4 | – | Sell |
-376
| Closed | -$23K | – | 256 |
|
|
2013
Q3 | $23K | Hold |
376
| – | – | 0.01% | 362 |
|
|
2013
Q2 | $23K | Buy |
+376
| New | +$22.4K | 0.02% | 331 |
|
Other funds holding DGX
Financial Architects (New Jersey)'s DGX Position: Q1 2023 in Review
Financial Architects (New Jersey) sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,455 shares — an estimated $228K sold.
Financial Architects (New Jersey) first reported a position in DGX in Q2 2013 and held it in 28 quarters. The position peaked at $324K in Q3 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.
- Financial Architects (New Jersey) reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
- Financial Architects (New Jersey) sold 1,455 Quest Diagnostics shares in Q1 2023, an estimated $228K.
- Financial Architects (New Jersey) first reported a position in Quest Diagnostics in Q2 2013 and held it in 28 quarters.
- Financial Architects (New Jersey)'s Quest Diagnostics position peaked at $324K in Q3 2021.
- 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q1 2023, filed 12 May 2023.